NURC
NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
01/03/2023
Back to search
Official data from USPTO
PROTODRUG
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
01/03/2023
Trademark type
Word
Nice classes
5
Filing date
11/06/2020
Registration date
07/05/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/05/2022
Last transaction
12/03/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Supplemental Register
Filing basis
Intent to use
First use anywhere
01/27/2021
First use in commerce
01/27/2021
Drawing code
4
Owner type
03
Owner location
San Francisco, CA
Examiner
GULIANO, ROBERT
Law office
L50
Current location
TMEG LAW OFFICE 105
Holders and representatives
Holders
Tambo, Inc.
Shasqi, Inc.
Representatives
Evan A. Raynes SYMBUS LAW GROUP PLLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations that are activated by click chemistry for the treatment of canceroncological disordersautoimmune diseasesinfectious diseasesinflammatory diseasesfibrotic diseaseshereditary diseasespain; Pharmaceutical preparations for the treatment of canceroncological disordersautoimmune diseasesinfectious diseasesinflammatory diseasesfibrotic diseaseshereditary diseasespain
Publications
History of USPTO decisions and trademark events.
30 publications found
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
11/26/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/26/2022
ES7R
TEAS SECTION 7 REQUEST RECEIVED
07/06/2022
NRCS
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/05/2022
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
07/05/2022
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
06/23/2022
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
05/27/2022
ALIE
ASSIGNED TO LIE
05/17/2022
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
05/13/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/04/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/03/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/03/2022
AAUA
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
11/04/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/03/2021
GNRT
NON-FINAL ACTION E-MAILED
11/03/2021
CNRT
NON-FINAL ACTION WRITTEN
11/03/2021
IUAA
USE AMENDMENT ACCEPTED
11/03/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/06/2021
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
10/06/2021
IUAF
USE AMENDMENT FILED
10/06/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/05/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/05/2021
EAAU
TEAS AMENDMENT OF USE RECEIVED
10/05/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/05/2021
GNRT
NON-FINAL ACTION E-MAILED
04/05/2021
CNRT
NON-FINAL ACTION WRITTEN
04/05/2021
DOCK
ASSIGNED TO EXAMINER
04/05/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/07/2021
NWAP
NEW APPLICATION ENTERED
11/10/2020
Continuous trademark protection
Get notified about every new filing that threatens PROTODRUG or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.